Alaska’s Congressional delegation is bracing for an FDA decision on genetically modified salmon and Sen. Mark Begich has asked the head of the agency not to exploit the holiday season to release what’s expected to be an unpopular report.

At issue is a U.S. company’s plan to create Atlantic salmon eggs for fish farms that include a Chinook salmon gene.

AquaBounty hopes to produce fish that grow to market size in half the time – Begich calls it Frankenfish.

“FDA has never approved anything of this nature, which is basically cloning, and from that perspective I don’t think they’re prepared to understand the potential long-term impacts,” Begich said.

Read the full story at Alaska Public Media>>